PrP-scrapie transport across intestinal & BBB

PrP-痒痒症跨肠道转运

基本信息

  • 批准号:
    6951191
  • 负责人:
  • 金额:
    $ 26.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-20 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The transmission of variant Creutzfeldt-Jakob disease (vCJD) to humans from bovine-spongiform encephalopathy (BSE)-contaminated meat, and the transmission of BSE by intra-venous inoculation of peripheral blood to experimental animals raises two important questions: 1) how are prions from food transported across the intestinal epithelial barrier, and 2) how do prions in the peripheral blood cross the endothelial blood brain barrier (BBB). These questions have gained increasing importance with the realization that close to one million BSE infected cows may have entered the human food chain. An emerging concern is the spread of Chronic Wasting Disease (CWD), a prion disease of the deer and elk in certain parts of USA, and the uncertainties regarding its transmission to livestock and humans. Despite these concerns, surprisingly little is known about the mechanism(s) by which the infectious prion or PrP-scrapie (PrPsc), a protein of 27-30kDa, is transported from the intestine or peripheral blood to the central nervous system. Preliminary data from my laboratory demonstrate that PrPsc in sporadic CJD (sCJD) brain homogenates is transported across epithelial cells in association with ferritin. When considered in context with additional data indicating an upregulation of brain ferritin levels in response to redox active iron in the brain parenchyma of sCJD cases, this observation raises important questions. We hypothesize that the transport of PrPsc across epithelial and endothelial cell barriers is facilitated by proteins like ferritin that have a defined transcytotic route, and that imbalance of brain iron homeostasis contributes directly to the pathogenesis of certain prion disorders, and indirectly by promoting infectivity through ferritin. Thus, the central goal of this proposal is to investigate the role of PrPs-associated proteins including ferritin and transferrin in facilitating its transport across the intestinal epithelium and the BBB, and to evaluate the role of redox active iron in the pathogenesis of prion disorders. The proposed studies will be carried out in three specific aims. In aim 1, the role of ferritin, transferrin, and other PrPsc-associated proteins in the transport of PrPsc across in vitro models of human intestinal epithelial cell barrier and the BBB will be evaluated. In aim 2, the results obtained from in vitro models in aim 1 will be confirmed in vivo in transgenic mice expressing human PrP. In aim 3, the role of redox active iron in the pathogenesis of priori disorders will be investigated using ferritin over-expressing and H-ferritin deletion transgenic mice. These studies will help in evaluating the risk of human population to BSE, vCJD, and CWD infection, and help in understanding the mechanism of prion disease pathogenesis.
描述(申请人提供):变异型克雅氏病(vCJD)通过牛海绵状脑病(BSE)污染的肉类传播给人类,以及BSE通过外周血静脉接种给实验动物传播,这提出了两个重要问题:1)食物中的朊病毒如何穿过肠上皮屏障,2)外周血中朊病毒如何穿过内皮血脑屏障(BBB)。随着近100万头感染疯牛病的奶牛可能已经进入人类食物链,这些问题变得越来越重要。一个新出现的问题是慢性消耗病(CWD)的传播,这是美国某些地区鹿和麋鹿的朊病毒疾病,以及其传播给牲畜和人类的不确定性。尽管存在这些问题,但令人惊讶的是,人们对感染性朊病毒或PrP-scrapie(PrPsc)(一种27- 30 kDa的蛋白质)从肠道或外周血转运到中枢神经系统的机制知之甚少。 从我的实验室的初步数据表明,在散发性克雅氏病(sCJD)脑匀浆中的PrPsc与铁蛋白运输通过上皮细胞。当考虑在上下文中与额外的数据表明上调脑铁蛋白水平的sCJD的情况下,脑实质中的氧化还原活性铁的反应,这一观察提出了重要的问题。我们假设,运输PrPsc跨上皮和内皮细胞屏障是由蛋白质,如铁蛋白,具有明确的转胞途径,脑铁稳态的不平衡直接有助于某些朊病毒疾病的发病机制,并间接通过促进感染性通过铁蛋白。因此,该建议的中心目标是研究PrPs相关蛋白包括铁蛋白和转铁蛋白在促进其跨肠上皮和血脑屏障的运输中的作用,并评估氧化还原活性铁在朊病毒疾病发病机制中的作用。拟议的研究将在三个具体目标下进行。在目标1中,将评估铁蛋白、转铁蛋白和其他PrPsc相关蛋白在PrPsc跨人肠上皮细胞屏障和BBB的体外模型转运中的作用。在目标2中,将在表达人PrP的转基因小鼠中体内证实目标1中从体外模型获得的结果。在目标3中,将使用铁蛋白过表达和H-铁蛋白缺失转基因小鼠研究氧化还原活性铁在先天性疾病发病机制中的作用。这些研究将有助于评估人群感染BSE、vCJD和CWD的风险,并有助于了解朊病毒病的发病机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Neena Singh其他文献

Neena Singh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Neena Singh', 18)}}的其他基金

Local hepcidin in the anterior segment: Physiological and pathological implications
眼前节局部铁调素:生理和病理学意义
  • 批准号:
    10370658
  • 财政年份:
    2022
  • 资助金额:
    $ 26.78万
  • 项目类别:
Local hepcidin in the anterior segment: Physiological and pathological implications
眼前节局部铁调素:生理和病理学意义
  • 批准号:
    10546487
  • 财政年份:
    2022
  • 资助金额:
    $ 26.78万
  • 项目类别:
Modulation of brain iron by local hepcidin in prion disorders
朊病毒病中局部铁调素对脑铁的调节
  • 批准号:
    10350851
  • 财政年份:
    2021
  • 资助金额:
    $ 26.78万
  • 项目类别:
Molecular Basis of Iron Imbalance in sCJD Brain and CSF
sCJD 脑和脑脊液中铁失衡的分子基础
  • 批准号:
    8417651
  • 财政年份:
    2012
  • 资助金额:
    $ 26.78万
  • 项目类别:
Molecular Basis of Iron Imbalance in sCJD Brain and CSF
sCJD 脑和脑脊液中铁失衡的分子基础
  • 批准号:
    8302810
  • 财政年份:
    2012
  • 资助金额:
    $ 26.78万
  • 项目类别:
Role of Brain Ferroxidases in AD and sCJD Pathogenesis
脑铁氧化酶在 AD 和 sCJD 发病机制中的作用
  • 批准号:
    8338829
  • 财政年份:
    2011
  • 资助金额:
    $ 26.78万
  • 项目类别:
Role of Brain Ferroxidases in AD and sCJD Pathogenesis
脑铁氧化酶在 AD 和 sCJD 发病机制中的作用
  • 批准号:
    8243115
  • 财政年份:
    2011
  • 资助金额:
    $ 26.78万
  • 项目类别:
The iron modulatory function of prion protein and prion disorders
朊病毒蛋白和朊病毒疾病的铁调节功能
  • 批准号:
    7906472
  • 财政年份:
    2010
  • 资助金额:
    $ 26.78万
  • 项目类别:
The iron modulatory function of prion protein and prion disorders
朊病毒蛋白和朊病毒疾病的铁调节功能
  • 批准号:
    8541551
  • 财政年份:
    2010
  • 资助金额:
    $ 26.78万
  • 项目类别:
The iron modulatory function of prion protein and prion disorders
朊病毒蛋白和朊病毒疾病的铁调节功能
  • 批准号:
    8287667
  • 财政年份:
    2010
  • 资助金额:
    $ 26.78万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.78万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 26.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了